With cannabis stocks beaten down in the last few months, the big rally by Aphria (APHA) following the release of FQ1 numbers is …
As if the bloodbath concerning cannabis stocks hasn’t been bad enough in 2019, the growing crisis surrounding vaping deaths and sicknesses has further …
Aphria (APHA) has had to battle itself out of a hole because of reputational issues coming from short-seller reports that suggested the company …
Just three months ago, Seaport analyst Brett Hundley was rolling back price targets on Canadian cannabis stocks, cutting forecasts for both sales and …
Only two months ago, Seaport Global was taking a cautious stance on Canadian cannabis company Aphria (APHA), cutting estimates for both sales and …
In the last two quarters, billionaire, hedge fund manager, and mathematical genius Jim Simons has moved decisively into the cannabis sector, taking large …
After hearing the latest earnings report from Aphria (APHA), it was good to see the company appear to start turning things around. Even …
It’s safe to say that Aphria (APHA) totally shocked the market and many of its investors after blowing its fiscal fourth-quarter earnings out …
By all accounts, Aphria (APHA) reported a better than expected FQ4 quarter for the period ending May 31. The Canadian cannabis company was …
With less than a week to go before Q4 earnings come out, eyes are beginning to turn to Canadian medical marijuana stock Aphria …
